603360.SHG Dalian Bio-Chem Co Ltd
- Market cap
- CNY 7.42B
- P/E
- 50.0x
- P/B
- 4.98x
- ROE
- 5.8%
- Dividend yield
- 4.47%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 603360.SHG undervalued?
Graham numberThe Graham number of Dalian Bio-Chem Co Ltd cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Dalian Bio-Chem Co Ltd fundamental analysis
No fundamental analysis for Dalian Bio-Chem Co Ltd yet.
Dalian Bio-Chem Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Dalian Bio-Chem Co Ltd
Dalian BIO-CHEM Company Limited engages in the research and development, production, and sale of industrial fungicides in China and internationally. It offers various isothiazolinone fungicides, including CMIT/MIT, MIT, OIT, DCOIT, and BIT series products; and OEM/ODM services. The company was founded in 2003 and is based in Dalian, China.
Full company profileDalian Bio-Chem Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Dalian Bio-Chem Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 389M | 410M | 528M | 872M | 750M | 1.01B | 1.26B | 1.07B | 1.31B | 1.72B | 1.08B |
| Gross Profit | 190M | 198M | 248M | 510M | 400M | 450M | 641M | 545M | 574M | 624M | 351M |
| Operating Income | 108M | 126M | 172M | 368M | 261M | 303M | 462M | 386M | 415M | 369M | 69.4M |
| EBITDA | 146M | 152M | 197M | 404M | 311M | 353M | 537M | 455M | 491M | 482M | 58.8M |
| Net Income | 98.3M | 100M | 145M | 307M | 222M | 250M | 403M | 328M | 345M | 210M | 81.7M |
| EPS | 0.18 | 0.15 | 0.20 | 0.43 | 0.31 | 0.36 | 0.58 | 0.47 | 0.49 | 0.30 | 0.12 |
| Balance Sheet | |||||||||||
| Total Assets | 626M | 779M | 897M | 1.19B | 1.43B | 1.67B | 1.75B | 1.94B | 3.64B | 3.89B | 3.87B |
| Total Liabilities | 168M | 92.9M | 99.3M | 156M | 441M | 621M | 293M | 305M | 1.29B | 1.86B | 1.82B |
| Shareholders' Equity | 459M | 688M | 799M | 1.03B | 988M | 1.05B | 1.46B | 1.64B | 1.79B | 1.39B | 1.40B |
| Cash & Short-term Investments | 114M | 134M | 71.6M | 242M | 343M | 295M | 418M | 600M | 668M | 1.17B | 845M |
| Total Debt | 75.0M | - | - | 30.0M | 300M | 339M | 129M | 150M | 533M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 120M | 76.0M | 135M | 240M | 211M | 142M | 480M | 390M | 163M | 547M | - |
| Capital Expenditure | 2.92M | 20.2M | 88.5M | 63.0M | 109M | 192M | 134M | 67.4M | 74.9M | 36.7M | 153M |
| Free Cash Flow | 117M | 55.8M | 46.7M | 177M | 101M | -49.6M | 346M | 322M | 88.1M | 510M | -240M |
| Ratios | |||||||||||
| ROE | 21.4% | 14.6% | 18.2% | 29.7% | 22.4% | 23.9% | 27.5% | 20.1% | 19.3% | 15.1% | 5.8% |
| ROA | 15.7% | 12.9% | 16.2% | 25.8% | 15.5% | 15.0% | 22.9% | 16.9% | 9.5% | 5.4% | 2.1% |
| Net Profit Margin | 25.2% | 24.4% | 27.5% | 35.2% | 29.6% | 24.9% | 32.0% | 30.8% | 26.3% | 12.2% | 7.6% |
| Debt to Equity | 0.16x | - | - | 0.03x | 0.30x | 0.32x | 0.09x | 0.09x | 0.30x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Dalian Bio-Chem Co Ltd dividends
- Dividend yield
- 4.47%
- Forward dividend
- -
- Payout ratio
- 158.0%
- Ex-dividend date
- May 29, 2025
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 332M | 0.47 | 158.0% |
| 2024 | CNY 224M | 0.31 | 64.8% |
| 2023 | CNY 207M | 0.30 | 63.0% |
| 2022 | CNY 6.50M | 0.01 | 1.6% |
| 2021 | CNY 150M | 0.22 | 59.9% |
| 2020 | CNY 112M | 0.16 | 50.5% |
| 2019 | CNY 72.8M | 0.10 | 23.7% |
| 2018 | CNY 34.3M | 0.05 | 23.6% |
| 2017 | CNY 134M | 0.20 | 133.8% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.4:1 on May 29, 2025.
Who owns Dalian Bio-Chem Co Ltd
- Insiders 58.35%
- Institutions 0.50%
- Public & others 41.15%
- Shares outstanding 706M
- Free float 252M
Dalian Bio-Chem Co Ltd company profile
- Company name
- Dalian Bio-Chem Co Ltd
- Ticker
- 603360.SHG
- ISIN
- CNE100002Z24
- Exchange
- Shanghai Stock Exchange
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 1,053
- Fiscal year end
- December
- Address
- Yifang Financial Plaza, Dalian, China, 116007
- Phone
- 86 411 8278 6111
- Website
- biofc.com
About Dalian Bio-Chem Co Ltd
Dalian BIO-CHEM Company Limited engages in the research and development, production, and sale of industrial fungicides in China and internationally. It offers various isothiazolinone fungicides, including CMIT/MIT, MIT, OIT, DCOIT, and BIT series products; and OEM/ODM services. The company was founded in 2003 and is based in Dalian, China.
Dalian Bio-Chem Co Ltd management
8- Mr. Hongjun LiuGM & Director · born 1970
- Mr. Pengcheng GaoFinancial Officer · born 1982
- Mr. Jie YangDeputy GM & Director · born 1968
- Mr. Weiming JiDeputy GM & Director · born 1971
- Mr. Chao WangBoard Secretary · born 1993
- Mr. Zhen Peng GuDeputy General Manager · born 1969
- Mr. Liangfeng ZhaoDeputy General Manager · born 1986
- Zhi Hai SunAccounting Supervisor